Methyltransferase like 3 (METTL3), an m6A “writer,” is upregulated in lenvatinib-resistant hepatocellular carcinoma, enhancing EGFR mRNA translation and activating ERK signaling [179]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.